Sundrug Co (TSE:9989) Beta: 0.0303 (As of Jun. 24, 2026)


TSE:9989 Sundrug Co Ltd TSE:9989
81 GF Score
Price 円3,768.00
GF Value 円4,717.16
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Sundrug Co Beta?

Sundrug Co TSE:9989 +0.11% 81 Beta is 0.0303 as of Jun. 24, 2026. GuruFocus rates TSE:9989 with a GF Score™ of 81/100 and a GF Value™ of 円4,717.16 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Sundrug Co's Beta is 0.0303.


Sundrug Co  (TSE:9989) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sundrug Co Beta Related Terms


Sundrug Co Beta Historical Data

* Premium members only.

The historical data trend for Sundrug Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sundrug Co Beta Chart

Sundrug Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.16 0.12 0.09 0.14

Sundrug Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.11 0.06 0.14

Sundrug Co Beta Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sundrug Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sundrug Co Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Beta distribution charts can be found below:

* The bar in red indicates where Sundrug Co's Beta falls into.


TSE:9989
81GF Score
Sundrug Co Ltd TSE:9989
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sundrug Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0303 mean?
Sundrug Co (TSE:9989) has a Beta of 0.0303 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sundrug Co and its competitors.
Is Sundrug Co's Beta too high?
Sundrug Co's current Beta is 0.0303. Overall, Sundrug Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Beta compare to competitors?
Sundrug Co's Beta of 0.0303 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sundrug Co and its competitors. Sundrug Co's current Beta is 0.0303. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Based on GuruFocus' analysis, Sundrug Co (TSE:9989) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,717.16, compared to a current price of 円3,768.00 — trading 20.1% below its estimated fair value. The current Beta is 0.0303. Sundrug Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Sundrug Co (TSE:9989), the current Beta is 0.0303 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sundrug Co (TSE:9989) Overvalued in 2026?

Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued. The current stock price of 円3,768.00 is trading 20.1% below its estimated GF Value™ of 円4,717.16. GuruFocus considers Sundrug Co to be Modestly Undervalued.

Key valuation signals for TSE:9989:

  • Beta: 0.0303
  • GF Value™: 円4,717.16 vs. price of 円3,768.00 (20.1% below fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the TSE:9989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sundrug Co Business Description

Address 1-38-1 Wakamatsucho, Fuchu-shi, Tokyo, JPN, 183-0005
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
81GF Score

Get the complete analysis for TSE:9989

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,768.00
Price
円4,717.16
GF Value